Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00268593
Recruitment Status : Completed
First Posted : December 22, 2005
Last Update Posted : June 15, 2011
Northern Sydney and Central Coast Area Health Service
Aventis Pharmaceuticals
Information provided by:
Progen Pharmaceuticals